AlphaVest director Hartzband resigns; Luo appointed to board and committees
AMC Robotics Corp
Brian Hartzband resigned from Board, Audit Committee, and Compensation Committee on Nov 25, 2024; no disagreement with company.
Jiangang Luo appointed as Class I director effective Nov 25, 2024; term expires at first annual meeting.
Luo appointed to Audit Committee and Compensation Committee; Board determined him independent under Nasdaq rules.
Luo is manager of Cleantech Global Limited (since 2014), president of Prime Science & Technology (since 2006), and CEO of Bowen Acquisition Corp (blank check company).
No cash compensation for directors; no arrangements or relationships requiring disclosure under Item 404(a).
On November 25, 2024 Brian Hartzband resigned as a member of the Board of Directors (the “Board”) of AlphaVest Acquisition Corp (the “Company”), as a member of the Audit Committee of the Board and the Compensation Committee of the Board.
Also on November 25, 2024, Jiangang Luo was appointed to the Board as a Class I director with his initial term expiring at the Company’s first annual meeting of stockholders.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Brian Hartzband resigned as Director at AMC Robotics Corp.
Action
resigned
Role
Director
Exact text from the filing
On November 25, 2024 Brian Hartzband resigned as a member of the Board of Directors (the “Board”) of AlphaVest Acquisition Corp (the “Company”), as a member of the Audit Committee of the Board and the Compensation Committee of the Board.
Jiangang Luo was appointed as Director at AMC Robotics Corp.
Action
appointed
Role
Director
Exact text from the filing
Also on November 25, 2024, Jiangang Luo was appointed to the Board as a Class I director with his initial term expiring at the Company’s first annual meeting of stockholders.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.